newsroompost
  • youtube
  • facebook
  • twitter
  1. Home

  2. Tag: DCGI

India launches investigation into 4 cough syrups after WHO warns on death of 66 children in Gambia

India launches investigation into 4 cough syrups after WHO warns on death of 66 children in Gambia

 Ayushi Sikarwar
Corbevax COVID-19 vaccine gets DCGI’s nod for children aged 5-12

Corbevax COVID-19 vaccine gets DCGI’s nod for children aged 5-12

 ANI
DCGI grants EUA to ZycovD COVID vaccine for two-dose regimen for children above 12

DCGI grants EUA to ZycovD COVID vaccine for two-dose regimen for children above 12

 ANI
DCGI gives emergency use authorisation to Covaxin for 6-12 age group

DCGI gives emergency use authorisation to Covaxin for 6-12 age group

 ANI
DCGI gives final approval to COVID-19 vaccine Corbevax for 12-18 year olds

DCGI gives final approval to COVID-19 vaccine Corbevax for 12-18 year olds

 ANI
84-yr-old Haryana man, first in India to get antibody cocktail against Covid-19 mutant

84-yr-old Haryana man, first in India to get antibody cocktail against Covid-19 mutant

 ANI
Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12 days: Govt

Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12 days: Govt

 Newsroom Staff
Vaccines approved are ‘110 % safe,’ says DCGI Chief VG Somani

Vaccines approved are ‘110 % safe,’ says DCGI Chief VG Somani

 Newsroom Staff
Covid-19 Vaccines are 110 % safe, says Drug Controller General of India

Covid-19 Vaccines are 110 % safe, says Drug Controller General of India

 Newsroom Staff
Pfizer India seeks emergency use authorisation from DCGI for its COVID-19 vaccine in the country

Pfizer India seeks emergency use authorisation from DCGI for its COVID-19 vaccine in the country

 Newsroom Staff

What's New

Don't Miss

newsroompost

About Us

This site is run and owned by Headlong NewsroomPost India Private Limited.

Quick Link

 

Important Link

© 2024, All Rights Reserved by Headlong Newsroom Post India Private Limited